Passing the Sniff test for Brain Disease
Date : 2024-01-15
Description
This summary was drafted with mixtral-8x7b-instruct-v0.1.Q5_K_M.gguf
The Micheal J Fox Foundation announced the discovery of a groundbreaking biomarker for Parkinson's disease (PD). The 'alpha-synuclein seeding amplification assay' (SAA) enables early detection and identification of PD with 90% specificity. This milestone holds immense potential in medical care provision, as it allows for more effective management of the disease prior to symptom onset. Furthermore, it provides a solid foundation for biomedical drug development efforts aimed at addressing PD. The SAA test is currently being integrated into drug trials, paving the way for significant advancements in understanding and treating Parkinson's disease.
Read article here
Recently on :
Health | Healthcare
WEB - 2024-02-05
What Your Brain Is Doing When You’re Not Doing Anything | Quantamagazine
Quantamagazine - The discovery of the default mode network, a collection of seemingly unrelated areas of the brain that activat...
WEB - 2024-01-24
AAV1-hOTOF gene therapy for autosomal recessive deafness | The Lancet
The Lancet - Jun Lv, Hui Wang, Xiaoting Cheng, Yuxin Chen, Daqi Wang, Longlong Zhang, Qi Cao, Honghai Tang, Shaowei Hu, Kaiyu ...
WEB - 2024-01-22
Loneliness and suicide mitigation for students using GPT3-enabled chatbots | Nature
Nature - Bethanie Maples, Merve Cerit, Aditya Vishwanath, and Roy Pea investigate how students use the Intelligent Social Agent...
WEB - 2024-01-15
Passing the Sniff test for Brain Disease
Michael J. Fox and Deborah W. Brooks discuss the discovery of a groundbreaking biomarker for Parkinson's disease (PD) is discus...
WEB - 2024-01-11
Towards Conversational Diagnostic AI
Tao Tu, Anil Palepu, Mike Schaekermann, Khaled Saab, Jan Freyberg, Ryutaro Tanno, Amy Wang, Brenna Li, Mohamed Amin, Nenad Toma...